Enforcement record
認定 disclosure naming 株式会社大賀薬局
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
認定
Law
産業競争力強化法
Authority
Ministry of Health, Labour and Welfare
Action date
30 September 2025
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-OTHER-DA-HE-YAO-J-202608041528
- Generated at
- 5 August 2026 at 00:28
- Record URL
- https://regbase.jp/en/enforcement/other-da-he-yao-ju-20250930
1. Review Summary
| Disclosure name | 株式会社大賀薬局 | Corporate Number | Not stated in the disclosure |
|---|---|---|---|
| Enforcement record | 1 record | Other confirmed records for this company | Outside this report's scope |
| Action date | 30 September 2025 | Authority | Ministry of Health, Labour and Welfare |
| Law | 産業競争力強化法 | Action type | 認定 |
| Source status | Preserved public-source archive recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Published Information
| Published name | 株式会社大賀薬局 |
|---|
3. Enforcement Record
| Target name in disclosure | 株式会社大賀薬局 |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | 産業競争力強化法 / 認定 |
| Action / announcement date | Action: 30 September 2025 / Announcement: 3 April 2026 |
| English summary | Regarding the 'Business Reorganization Plan' submitted by Oga Holdings Co., Ltd. and Oga Pharmacy Co., Ltd., a review was conducted based on Article 23, Paragraph 1 of the Act on Strengthening Industrial Competitiveness. It was determined that the planned business reorganization qualifies as a reorganization under Article 2, Paragraph 17 of the same Act and meets the certification requirements stipulated by the Act. Therefore, the plan was certified. |
| Original Japanese text | 株式会社オーガホールディングス及び株式会社大賀薬局から提出された「事業再編計画」について、産業競争力強化法第23条第1項の規定に基づき審査した結果、同法第2条第17項に規定する事業再編を実施するものとして、同法で定める認定要件を満たすと認められるため、「事業再編計画」の認定を行いました。 |
| Official source | https://www.mhlw.go.jp/stf/newpage_63961.html |
| Source archive | https://kiroku.today/a/5f03082a08hfc39v |
| Extraction / evidence timestamps | Extracted: 25 April 2026 at 08:39 / Evidence checked: 25 April 2026 at 08:39 / Archive captured: 12 July 2026 at 15:41 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Confirmed Records for This Company
This report covers the single government disclosure shown on this page.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Free report
Save the disclosure record naming 株式会社大賀薬局
Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Preserved evidence by Kiroku
Review the preserved source for 株式会社大賀薬局
Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- 株式会社大賀薬局Japanese onlyOriginal: 株式会社大賀薬局
- Governing law
- 産業競争力強化法産業競争力強化法
- Action type
- 認定認定
- Action date
- 30 September 2025
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品・薬局
Violation
Regarding the 'Business Reorganization Plan' submitted by Oga Holdings Co., Ltd. and Oga Pharmacy Co., Ltd., a review was conducted based on Article 23, Paragraph 1 of the Act on Strengthening Industrial Competitiveness. It was determined that the planned business reorganization qualifies as a reorganization under Article 2, Paragraph 17 of the same Act and meets the certification requirements stipulated by the Act. Therefore, the plan was certified.
Show original Japanese text
株式会社オーガホールディングス及び株式会社大賀薬局から提出された「事業再編計画」について、産業競争力強化法第23条第1項の規定に基づき審査した結果、同法第2条第17項に規定する事業再編を実施するものとして、同法で定める認定要件を満たすと認められるため、「事業再編計画」の認定を行いました。
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under 産業競争力強化法.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-24T23:39:02.554+00:00
- Evidence checked
- 2026-04-24T23:39:02.554+00:00
- Archive captured
- 2026-07-12T06:41:43.801866+00:00
Show audit JSON
{
"record": {
"id": "2a195c53-cea7-4c33-b82c-cfcc5efed10c",
"url": "https://regbase.jp/en/enforcement/other-da-he-yao-ju-20250930",
"company_name_original": "株式会社大賀薬局",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "産業競争力強化法",
"en": "産業競争力強化法"
},
"action_type": {
"ja": "認定",
"en": "認定"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (株式会社大賀薬局). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under 産業競争力強化法."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-da-he-yao-ju-20250930",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_63961.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/5f03082a08hfc39v",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_63961.html",
"archiveCapturedAt": "2026-07-12T06:41:43.801866+00:00",
"extractedAt": "2026-04-24T23:39:02.554+00:00",
"translatedAt": "2026-05-01T06:53:02.6+00:00",
"evidenceCheckedAt": "2026-04-24T23:39:02.554+00:00",
"generatedAt": "2026-08-04T15:28:02.580Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.